2020 Pediatric Rheumatology Symposium

April 29-May 2, 2020

The 2020 Pediatric Rheumatology Symposium, originally scheduled for April 29 – May 2, was postponed due to COVID-19; therefore, abstracts were not presented as scheduled.

View by Number View by Title View Sessions

View by Date

Thursday, April 30, 2020

2:30PM-3:30PM: Abstract Number: 003

Implementing Treat to Target Approach in the Care of Juvenile Idiopathic Arthritis Across a Network of Pediatric Rheumatology Centers

Plenary Abstracts Session 1

2:30PM-3:30PM: Abstract Number: 004

Implications of Adopting the Newly Proposed Pediatric Rheumatology International Trials Organization (PRINTO) Classification Criteria for Juvenile Idiopathic Arthritis (JIA): Results from the Research in Arthritis in Canadian Children, Emphasizing Outcomes (ReACCh-Out) Cohort

Plenary Abstracts Session 1

2:30PM-3:30PM: Abstract Number: 001

WITHDRAWN

Plenary Abstracts Session 1

2:30PM-3:30PM: Abstract Number: 002

WITHDRAWN

Plenary Abstracts Session 1

5:10PM-5:40PM: Abstract Number: 013

A Preliminary Data-driven Anatomic Classification for Childhood Takayasu Arteritis (cTA)

Poster Breakout 1 – Advances in Diagnosis & Classification

5:10PM-5:40PM: Abstract Number: 024

Abatacept Treatment Reduces Cutaneous and Joint Activity in Juvenile Localized Scleroderma

Poster Breakout 3 – Scleroderma, Myositis, & Miscellaneous

5:10PM-5:40PM: Abstract Number: 022

Association of Plasma Metabolomic Profiles with Methotrexate Response in Juvenile Idiopathic Arthritis

Poster Breakout 3 – Scleroderma, Myositis, & Miscellaneous

5:10PM-5:40PM: Abstract Number: 023

Capturing the Range of Disease Involvement in Localized Scleroderma: The Total Morbidity Score

Poster Breakout 3 – Scleroderma, Myositis, & Miscellaneous

5:10PM-5:40PM: Abstract Number: 019

Characterization of DOCK8 as a Novel Gene Associated with Cytokine Storm Syndrome

Poster Breakout 2 – Genetics & Pathogenesis

5:10PM-5:40PM: Abstract Number: 011

Chronic Non-bacterial Osteomyelitis (CNO): Correlation Between Clinical and Radiological Findings

Poster Breakout 1 – Advances in Diagnosis & Classification

5:10PM-5:40PM: Abstract Number: 018

Functional Characterization of PLCG2 Mutations Found in Subjects with Autoinflammation and PLCG2-Associated Antibody Deficiency and Immune Dysregulation (APLAID) Reveals Both Hypermorphic and Hypomorphic Mutants

Poster Breakout 2 – Genetics & Pathogenesis

5:10PM-5:40PM: Abstract Number: 016

Genetic Susceptibility Loci for Periodic Fever, Aphthous Stomatitis, Pharyngitis and Cervical Adenitis (PFAPA) Syndrome

Poster Breakout 2 – Genetics & Pathogenesis

5:10PM-5:40PM: Abstract Number: 025

HLA Genetic Signatures Associated with Inflammatory Sub-type in Juvenile Localized Scleroderma

Poster Breakout 3 – Scleroderma, Myositis, & Miscellaneous

5:10PM-5:40PM: Abstract Number: 020

Murine Roseolovirus Induces Autoimmune Disease and Development of Autoantibodies

Poster Breakout 2 – Genetics & Pathogenesis

5:10PM-5:40PM: Abstract Number: 017

MyD88 S209R-Mediated Immune Dysregulation in Mouse Models of Arthritis

Poster Breakout 2 – Genetics & Pathogenesis

1
2
3
…
5
Next Page»

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].